- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07388966
Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia (SKY-MOT3)
Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia Using Syde®
The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Ferial Toumi
- Telefoonnummer: +33 2 78 00 10 98
- E-mail: ferial.toumi@sysnav.fr
Studie Locaties
-
-
-
Liège, België, 4000
- Nog niet aan het werven
- Hôpital de la Citadelle
-
Hoofdonderzoeker:
- Julie HARVENGT
-
Liège, België, 4000
- Nog niet aan het werven
- CHU de Liège
-
Hoofdonderzoeker:
- Julie HARVENGT
-
-
-
-
-
Paris, Frankrijk, 75015
- Werving
- Hopital Necker
-
Contact:
- Na An
- Telefoonnummer: +33 1 71 19 64 73
- E-mail: na.an@aphp.fr
-
Hoofdonderzoeker:
- Genevieve Baujat
-
Onderonderzoeker:
- Soo Kyung Kim
-
-
-
-
-
London, Verenigd Koninkrijk
- Nog niet aan het werven
- Myriad Trials
-
Hoofdonderzoeker:
- Melita IRVING
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
France: Participants will be recruited from the patient registry of the Centre de Référence des Maladies Osseuses Constitutionnelles located at Necker Hospital / IMAGINE Institute. The APPT association (Association des Personnes de Petite Taille) will also help with the recruitment through flyers distribution. All visits will take place at Necker Hospital.
Belgium: Participants will be recruited from the Maladies Rares Génétiques Ostéo-articulaires (MaRGOs) patient registry located at Centre Hospitalier Universitaire (CHU) de Liège, with additional recruitment through Centre Hospitalier Régional (CHR) de Liège and support from the Solidarité Wallonne des Personnes de Petite Taille association through flyer distribution. All visits will take place at CHU de Liège and CHR de Liège.
United Kingdom: Participants will be recruited from the Site Research Waiting List
Beschrijving
Inclusion Criteria:
1.a. Aged 2 years old or older at the time of consent (France and Belgium)
-
b. Aged between 2 years old and < 17 years old at the time of consent (United Kingdom)
-
Written informed consent obtained:
- From the parent(s) or legal guardian(s) for participants under 18 years old.
- From participants 18 years old and older.
-
Affiliated to, or beneficiary of a social security category (not applicable for the United Kingdom)
-
Able to walk unassisted for at least 10 meters.
-
Genetically confirmed diagnosis with one pathogenic variant (ACMG class IV & V) of achondroplasia or hypochondroplasia.
-
Participant (and caregivers for participants under 18 years old) willing and able to comply with all study procedures including: questionnaires, Syde® related procedures
Exclusion Criteria:
- Subjects who have short stature condition other than ACH/HCH.
- Presence of cognitive disorders that limit their understanding of the data collection process (training of device use and 4-week recording periods every 6 months, device return at the end of the study), the implication of the study and consent.
- Presence or history of any concurrent disease or condition that could interfere with study participation, impact pediatric growth, affect motor or balance or gait function (such as neurological, endocrine, infectious, allergic, osteoarthritis, or inflammatory), assessed by the investigator.
- Females who are pregnant, or planning to become pregnant during the study duration.
- Body Mass Index = 35 kg/m2.
- Recent upper and/or lower limbs injury (trauma/fracture or surgery) in the 6 months preceding inclusion.
- Prior limb lengthening surgery or planned or expected to have limb lengthening surgery while enrolled in the study.
- Presence of guided growth hardware (such as 8-plates) or planned orthopedic surgeries during the study.
- Vulnerable patient (guardianship, curatorship or safeguarding of justice), unable to provide informed consent or who is unable to express their consent.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Reliability of digital endpoint derived from Syde® assessed by the Intra-Class Correlation (ICC) for each recording period timepoint.
Tijdsspanne: 12 months
|
reliability assessed by the ICC (Intra-Class Correlation)for each recording period timepoint (baseline, 6 months, 12 months) |
12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
number of participants reaching 180 hours of recording during the recording periods defined in the protocol
Tijdsspanne: 12 months
|
Number of patients reaching 180 hours of recordings during the recording periods defined in the protocol (supposed optimal threshold for Syde®-derived digital endpoint computation) at baseline, 6 months, 12 months |
12 months
|
|
System Usability Score (F-SUS) score at 6 months of Syde® use
Tijdsspanne: 6 months
|
System Usability Score (SUS) at 6 months. The System Usability Scale is a 10-item questionnaire . It is a simple tool to measure the usability of an interactive system and it is widely used. For each item, the user is asked to express their level of agreement or disagreement from 1 (strongly disagree) and 5 (strongly agree). |
6 months
|
|
Correlation between digital endpoints derived from Syde® and 6-minutes walk test (6MWT)
Tijdsspanne: 12 months
|
Correlation at baseline and at different timepoints between Syde® derived digital endpoint and 6MWT |
12 months
|
|
Correlation between digital endpoints derived from Syde® and growth parameters
Tijdsspanne: 12 months
|
Correlation at baseline and at different timepoints between Syde® derived digital endpoints and annualized growth velocity, height Z-score, body proportion ratios |
12 months
|
|
Correlation between digital endpoints derived from Syde® and Patient-reported Outcomes (PROs)
Tijdsspanne: 12 months
|
Correlation at baseline and at different timepoints between Syde® derived digital endpoints and PROs |
12 months
|
|
Longitudinal Change in digital endpoints derived from Syde®
Tijdsspanne: 12 months
|
Change from baseline in digital endpoints derived from Syde® at 6 and 12 months |
12 months
|
|
Syde® movement reconstruction accuracy compared to Optical Motion Capture measures.
Tijdsspanne: Baseline
|
Stride detection accuracy of Syde®, stride length and stride velocity accuracy of Syde® and upper limb measures, compared to Optical Motion Capture measures |
Baseline
|
|
Qualitative interview exploring limitations on mobility and impact on daily life
Tijdsspanne: baseline
|
caregiver and/or participant qualitative interview exploring limitations on mobility daily life |
baseline
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Genevieve Baujat, Hopital Necker
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PR5030-108
- 2025-A01608-41 (Andere identificatie: ANSM)
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .